Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The British Journal of Dermatology|May 18, 2011
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasisB E Strober, J J Crowley, P S Yamauchi, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosyP S Yamauchi, J R Bleharski, K Uyemura, et al.The Journal of Dermatological Treatment|May 1, 2020
Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trialsK B Gordon, K Reich, J J Crowley, et al.The British Journal of Dermatology|June 11, 2017
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)A Blauvelt, L K Ferris, P S Yamauchi, et al.Pageof 2